MCLEAN, Va., April 05, 2016 -- Gladstone Commercial Corporation (NASDAQ:GOOD) (“Gladstone Commercial”) announced today that its property located at 717 East Parmer Lane in Austin, Texas has earned the U.S. Environmental Protection Agency’s (“EPA’s”) ENERGY STAR certification for 2015. This designation signifies that the building performs in the top 25 percent of similar facilities nationwide for energy efficiency and meets strict energy efficiency performance levels set by the EPA.
The property is one of 11 General Motors facilities that has earned the ENERGY STAR certification for superior energy efficiency from the U.S. Environmental Protection Agency.
“We are excited that General Motors selected this property in the high growth Parmer Corridor of Austin as part of its corporate commitment to making its global operations more energy efficient,” remarked Buzz Cooper, Senior Managing Director of Gladstone Commercial. “We look forward to working with additional tenants on similar projects aimed to increase energy efficiency and reduce costs.”
About Gladstone Commercial Corporation (NASDAQ:GOOD)
Gladstone Commercial is a real estate investment trust focused on acquiring, owning and operating net leased industrial and office properties across the United States. Gladstone Commercial’s real estate portfolio consists of 99 properties located in 24 states, totaling approximately 11.0 million square feet. For additional information please visit www.gladstonecommercial.com.
For Broker Submittals:
| South/Southwest: | Midwest/Northeast: | ||||
| Buzz Cooper | Matt Tucker | ||||
| Senior Managing Director | Managing Director | ||||
| (703) 287-5815 | (703) 287-5830 | ||||
| [email protected] | [email protected] | ||||
| West: | Tennessee/Kentucky: | ||||
| Andrew White | Brandon Flickinger | ||||
| Managing Director | Director | ||||
| (310) 953-4960 | (703) 287-5819 | ||||
| [email protected] | [email protected] | ||||
Investor or Media Inquiries:
| Bob Cutlip | |
| President – Gladstone Commercial Corporation | |
| (703) 287-5878 | |
| [email protected] | |
All statements contained in this press release, other than historical facts, may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Readers should not rely upon forward-looking statements because the matters they describe are subject to known and unknown risks and uncertainties that could cause the Company's business, financial condition, liquidity, results of operations, funds from operations or prospects to differ materially from those expressed in or implied by such statements. Such risks and uncertainties are disclosed under the caption "Risk Factors" of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015, as filed with the SEC on February 17, 2016. The Company cautions readers not to place undue reliance on any such forward-looking statements which speak only as of the date made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For Investor Relations inquiries related to any of the monthly dividend paying Gladstone funds, please visit www.gladstone.com.


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Italy Fines Apple €98.6 Million Over App Store Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 



